Remarkably, these Alkal2;Th‐MYCN‐driven NBs are similar to ALK gain‐of‐function‐driven NB as assessed by RNA‐Seq and moreover respond to ALK TKI treatment. The gene discussed is MYCN; the disease is neuroblastoma.